- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01834118
Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension (RETREAT)
Reintervention After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
Study Overview
Status
Intervention / Treatment
Detailed Description
Renal Denervation is a CE-certified opportunity for treating patients with therapy-refractory hypertension. In some patients it doesn't show a significant lowering of the blood pressure, so a repeated renal denervation is an option.
In this study repeated renal denervation will be performed with the Recor Paradise Ultrasound Catheter.
For the study no specific procedures are required which would exceed the standard renal denervation procedure with the CE-certified Recor Paradise Ultrasound Catheter System.
There are no additional risks for the patient in consequence of participating in the study or the follow up procedures.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Hessen
-
Frankfurt, Hessen, Germany, 60389
- Cardiovascular Center Frankfurt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individual is ≥18 years old
- Individual received renal denervation ≥12 months prior to study participation to no therapeutical avail and is scheduled for reintervention.
- Systolic Office based blood pressure ≥140mmHg
- Individual receives 3 or more antihypertensive drugs including one diuretic
- Individual is willing to provide written informed consent to participate in this study
Exclusion Criteria:
- Individual has hypertension secondary to an identifiable and treatable cause
- Individual has any serious medical condition which in the opinion of the investigator may adversely affect the participation.
- Individual is pregnant, nursing or planning to be pregnant
- Renal artery abnormalities which may affect the procedure
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Office Blood pressure measurement
Time Frame: up to1 year
|
up to1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Horst Sievert, M.D., Cardiovascular Center Frankfurt
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CVC-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension, Resistant to Conventional Therapy
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI); Emory UniversityNot yet recruitingHypertension, Resistant to Conventional TherapyUnited States
-
Memorial Health University Medical CenterUnknownHypertension, Resistant to Conventional TherapyUnited States
-
University of CambridgeBritish Heart FoundationUnknownHypertension, Resistant to Conventional TherapyUnited Kingdom
-
Mayo ClinicWithdrawnHypertension, Resistant to Conventional TherapyUnited States
-
Tomsk National Research Medical Center of the Russian...Completed
-
University of ZurichTerminatedHypertension, Resistant to Conventional TherapySwitzerland
-
Hannover Medical SchoolMayo Clinic; Charite University, Berlin, Germany; University of Bristol; Vanderbilt...CompletedHypertension, Resistant to Conventional TherapyGermany
-
Universidade Federal de GoiasUnknownHypertension, Resistant to Conventional TherapyBrazil
-
Chinese Academy of Medical Sciences, Fuwai HospitalHuazhong University of Science and Technology; Shanghai Jiao Tong University...UnknownThe Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis (doublepres)Hypertension, Resistant to Conventional TherapyChina
-
Oslo University HospitalUnknownHypertension, Resistant to Conventional TherapyNorway
Clinical Trials on Renal Denervation
-
Vivek ReddyCompletedVentricular TachycardiaUnited States, Czechia, Russian Federation
-
Medtronic VascularCompletedCardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
University Hospital, SaarlandWithdrawnChronic Heart Failure | Cardio-Renal SyndromeAustria, Germany, Switzerland, Sweden
-
Vivek ReddyCompletedAtrial Fibrillation | Uncontrolled HypertensionUnited States, Czechia, Russian Federation
-
Tomsk National Research Medical Center of the Russian...Completed
-
Baker Heart and Diabetes InstituteCompletedHypertension | End-stage Renal DiseaseAustralia
-
Medtronic VascularCompleted
-
Charles University, Czech RepublicMount Sinai Hospital, New York; General University Hospital, Prague; Na Homolce...UnknownArterial Hypertension | Chronic Renal InsufficiencyCzech Republic
-
ReCor Medical, Inc.Active, not recruitingCardiovascular Diseases | Vascular Diseases | HypertensionUnited States, United Kingdom, Netherlands, France, Ireland, Belgium, Germany, Switzerland
-
Baker Heart and Diabetes InstituteTerminated